🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Fleur Hudson

Fleur Hudson

MRC Clinical Trials Unit at UCL

ORCID: 0000-0001-5891-7514

Also affiliated with University College London

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial”.

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6

N/A

4.5DataRank · unranked

128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

The Lancet(2022)10.1016/s0140-6736(22)00101-5

N/A

3.1DataRank · unranked

77 citations

Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu +83 more

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00147-9

N/A

0.869DataRank · unranked

19 citations

Christina E. Barkauskas, Birgit Grund, Shweta Sharma, Andrew Phillips, Lindsay Leither +95 more

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Wellcome Open Research(2021)10.12688/wellcomeopenres.16594.1

N/A

0.292DataRank · unranked

6 citations

Sarah Pett, Leanne McCabe, Christopher R. Jones, Richard Gilson, Sumita Verma +20 more

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

Scientific Reports(2023)10.1038/s41598-023-29739-x

N/A

0.241DataRank · unranked

4 citations

Sarah Samorodnitsky, Chris H. Wendt, Jason V. Baker, Gary Collins, Monica Kruk +95 more

Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease

Nature Communications(2025)10.1038/s41467-025-67174-w

N/A

0.208DataRank · unranked

3 citations

Tomke Arand, Ha Gyu-Thomas Seong, Christian Heuss, Margaret Tulessin, Zhiqing Wang +49 more

The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study

EBioMedicine(2022)10.1016/j.ebiom.2022.104206

N/A

0DataRank · unranked

22 citations

Chen Xi Yang, Julia Yang, Xuan Li, Steve Horvath, Tawimas Shaipanich +44 more

Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

medRxiv(2021)10.1101/2021.01.22.21250208

N/A

0DataRank · unranked

0 citations

Sarah Pett, Leanne McCabe, Christopher R. Jones, Richard Gilson, Sumita Verma +20 more

Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia

UNC Libraries(2021)10.17615/7t6d-3997

N/A

0DataRank · unranked

0 citations

R. Warrier, A.O. Westfall, Fleur Hudson, L. Mulenga, M.S. Saag +4 more

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)

Clinical Trials(2021)10.1177/17407745211049829

N/A

0DataRank · unranked

34 citations

Abdel G. Babiker, Jason V. Baker, Christina E. Barkauskas, Samuel M. Brown, Christina C. Chang +23 more

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size

Clinical Infectious Diseases(2022)10.1093/cid/ciac249

N/A

0DataRank · unranked

11 citations

Sunil K. Ahuja, Locadiah Kuwanda, Michael J. Vjecha, Fleur Hudson, Luxshimi Lal +23 more

Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection

The Journal of Experimental Medicine(2024)10.1084/jem.20241091

N/A

0DataRank · unranked

10 citations

Ce Gao, Gregory T. Gladkov, Isabelle Roseto, Leah Carrere, Elizabeth M. Parsons +91 more